Artificial intelligence stands to ‘revolutionize’ clinical trial research: KPMG report

The use of advanced analytical technologies like artificial intelligence (AI) and machine learning (ML) is not exactly new to the field of clinical trials. However, the use of such tools has exploded in recent years, due to several factors; according to a recent industry report by KPMG , the pandemic has accelerated AI’s adoption so much it has been termed “COVID-19 whiplash.” Bioclinica chief innovation officer Dan Gebow, who has years of experience harnessing AI, spoke with Outsourcing-Pharma about the evolution of AI in clinical research, and his own experience in helping shape …

Read the source article at outsourcing-pharma.com
2021-08-05 18:35:00